milrinone has been researched along with Mitral Valve Stenosis in 5 studies
Mitral Valve Stenosis: Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effects of dobutamine and nitroglycerin to milrinone in young patients with severe pulmonary hypertension undergoing mitral valve replacement." | 9.27 | Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study. ( Abu Elkassem, MS; Elmiligy, AE; Eskandr, AM; Hussein, L; Metwally, AA; Mourad, M; Sadik, SA, 2018) |
| "The phosphodiesterase inhibitor milrinone is usually preferred in patients with pulmonary hypertension and myocardial dysfunction after cardiopulmonary bypass." | 9.12 | Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension. ( Canik, S; Goksel, O; Issever, H; Oztekin, DS; Oztekin, I; Yazici, S, 2007) |
| "To evaluate and compare the hemodynamic effects of intraoperative intravenous milrinone versus inhalational milrinone at two timepoints in patients with severe pulmonary hypertension undergoing mitral valve surgery." | 8.02 | Inhaled versus intravenous milrinone in mitral stenosis with pulmonary hypertension. ( Garg, P; Patel, J; Patel, K; Patel, S, 2021) |
| "To compare the effects of dobutamine and nitroglycerin to milrinone in young patients with severe pulmonary hypertension undergoing mitral valve replacement." | 5.27 | Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study. ( Abu Elkassem, MS; Elmiligy, AE; Eskandr, AM; Hussein, L; Metwally, AA; Mourad, M; Sadik, SA, 2018) |
| "The phosphodiesterase inhibitor milrinone is usually preferred in patients with pulmonary hypertension and myocardial dysfunction after cardiopulmonary bypass." | 5.12 | Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension. ( Canik, S; Goksel, O; Issever, H; Oztekin, DS; Oztekin, I; Yazici, S, 2007) |
| "To evaluate and compare the hemodynamic effects of intraoperative intravenous milrinone versus inhalational milrinone at two timepoints in patients with severe pulmonary hypertension undergoing mitral valve surgery." | 4.02 | Inhaled versus intravenous milrinone in mitral stenosis with pulmonary hypertension. ( Garg, P; Patel, J; Patel, K; Patel, S, 2021) |
| "A 42-year-old man with dilated cardiomyopathy and rheumatic mitral stenosis underwent mitral valve replacement." | 1.30 | [Anesthetic management for mitral valve replacement in a patient with mitral stenosis and dilated cardiomyopathy]. ( Fujihara, H; Fukuda, S; Kurokawa, S; Shimoji, K; Tobita, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, J | 1 |
| Patel, K | 1 |
| Garg, P | 1 |
| Patel, S | 1 |
| Eskandr, AM | 1 |
| Metwally, AA | 1 |
| Abu Elkassem, MS | 1 |
| Sadik, SA | 1 |
| Elmiligy, AE | 1 |
| Mourad, M | 1 |
| Hussein, L | 1 |
| Nakamura, T | 1 |
| Ikeshita, K | 1 |
| Shimizu, M | 1 |
| Miyake, W | 1 |
| Ikeda, Y | 1 |
| Asada, A | 1 |
| Oztekin, I | 1 |
| Yazici, S | 1 |
| Oztekin, DS | 1 |
| Goksel, O | 1 |
| Issever, H | 1 |
| Canik, S | 1 |
| Kurokawa, S | 1 |
| Fujihara, H | 1 |
| Tobita, T | 1 |
| Fukuda, S | 1 |
| Shimoji, K | 1 |
2 trials available for milrinone and Mitral Valve Stenosis
| Article | Year |
|---|---|
Dobutamine and Nitroglycerin Versus Milrinone for Perioperative Management of Pulmonary Hypertension in Mitral Valve Surgery. A Randomized Controlled Study.
Topics: Adolescent; Adrenergic beta-1 Receptor Agonists; Adult; Dobutamine; Dose-Response Relationship, Drug | 2018 |
Effects of low-dose milrinone on weaning from cardiopulmonary bypass and after in patients with mitral stenosis and pulmonary hypertension.
Topics: Adult; Cardiopulmonary Bypass; Female; Heart Valve Prosthesis Implantation; Humans; Hypertension, Pu | 2007 |
3 other studies available for milrinone and Mitral Valve Stenosis
| Article | Year |
|---|---|
Inhaled versus intravenous milrinone in mitral stenosis with pulmonary hypertension.
Topics: Administration, Inhalation; Administration, Intravenous; Adult; Antihypertensive Agents; Cardiopulmo | 2021 |
[Anesthetic management for mitral valve replacement in a patient with mitral stenosis and dilated cardiomyopathy].
Topics: Aged; Anesthesia, General; Cardiomyopathy, Dilated; Cardiopulmonary Bypass; Heart Valve Prosthesis I | 2011 |
[Anesthetic management for mitral valve replacement in a patient with mitral stenosis and dilated cardiomyopathy].
Topics: Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Cardiomyopathy, Dilated; Dobutamine; Dopam | 1999 |